Elbit Imaging Ltd. (EMITF)
Stock Price: $2.44 USD
-0.02 (-0.81%)
Updated Jun 11, 2021 10:07 AM EDT - Market closed
| Market Cap | 22.54M |
| Revenue (ttm) | 22.65M |
| Net Income (ttm) | -137.72M |
| Shares Out | 9.19M |
| EPS (ttm) | -8.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | $0.08 |
| Dividend Yield | 3.28% |
| Trading Day | June 11 |
| Last Price | $2.44 |
| Previous Close | $2.46 |
| Change ($) | -0.02 |
| Change (%) | -0.81% |
| Day's Open | 2.44 |
| Day's Range | 2.44 - 2.44 |
| Day's Volume | 1,020 |
| 52-Week Range | 0.77 - 2.52 |
News
There are no news available yet.
About EMITF
Elbit Imaging Ltd., together with its subsidiaries, engages in research and development, production, and marketing of treatment-oriented medical systems; and products to treat cancer diseases. Its treatment-oriented medical systems include magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings. The company is also involved in the sale of plots in India. It has operations in the United States, Europe, and internationally. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.
| Industry Medical Devices | IPO Date Nov 27, 1996 |
| CEO Ron Hadassi | Employees 4 |
| Stock Exchange OTCMKTS | Ticker Symbol EMITF |